Search for: "Isom v. Isom" Results 61 - 80 of 136
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2014, 2:01 am by Lawrence B. Ebert
Perhaps the most important exclusion from patentability, discussed further below, is India’s Section 3(d).The authors cited Pfizer v. [read post]
2 Oct 2013, 8:58 am by Gene Quinn
On September 26, 2013, the United States Court of Appeals for the Federal Circuit issued a panel decision in Sunovion Pharmaceuticals v. [read post]
11 Oct 2012, 3:48 pm by John W. Arden
Instead, Merck’s allegations focused almost entirely on losses suffered by Merck itself, not the eventual—and theoretical— harm suffered by the public at large.The opinion in Merck Eprova AG v. [read post]